Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma

Abstract

Abstract Background and Objective: Lung adenocarcinoma is the most common and aggressive subtype of lung cancer, with the poor overall prognosis. IL2 is one of the earliest cytokines discovered that stimulates lymphocyte proliferation. However, the role of IL2 in LUAD has not been clarified. Methods: UALCAN, The HPA and TIMER database were used to investigate IL2 expression in LUAD. HPA, PrognoScan Database Analysis and Kaplan-Meier plotter database were used to explore the survival curve evaluating the prognostic value of IL2 for LUAD. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of IL2-interacting genes identified by GeneMANIA database. TIMER was used to analyze the correlation of IL2 and immune cell infiltration or immune checkpoint expression level in LUAD. Results: In present study, the results showed that the expression of IL-2 in lung adenocarcinoma was lower than that in the normal control group by means of bioinformatics analysis of the TIMER, UALCAN and HPA public databases. Moreover, LUAD patients with downregulated IL2 expression exhibited poor overall survival. Besides, IL2 was significantly positively correlated with various immune cells, including B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells in LUAD. And IL2 was also markedly positively associated with biomarkers of these infiltrated immune cells. IL2 expression was also positively correlated with PD-1, PD-L1 and CTLA-4 expression. Conclusion: In summary, our results indicate that down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in LUAD and IL2 could serve as a potential novel prognostic biomarker for LUAD.